期 |
栏目 |
标题 |
文件 |
卷 93, 编号 4 (2021) |
Reviews |
Exocrine pancreas insufficiency: clinical significance and approaches to correction from evidence medicine |
 (Rus)
|
卷 93, 编号 8 (2021) |
Original articles |
Efficacy of trimebutine in the treatment of functional gastrointestinal disorders: an observational multicenter study |
 (Rus)
|
卷 93, 编号 8 (2021) |
Reviews |
Obesity as a risk factor for diseases of the digestive system |
 (Rus)
|
卷 93, 编号 12 (2021) |
Original articles |
Complex assessment of esophageal acidification and motor function in patients with Barrett's esophagus on antisecretory therapy |
 (Rus)
|
卷 94, 编号 2 (2022) |
Original articles |
The effectiveness of eradication therapy of the 1st line of Helicobacter pylori infection in patients with type 2 diabetes mellitus |
 (Rus)
|
卷 94, 编号 8 (2022) |
GUIDELINES |
Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians |
 (Rus)
|
卷 94, 编号 8 (2022) |
Original articles |
Composition of oropharyngeal microbiota in patients with COVID-19 of different pneumonia severity |
 (Rus)
|
卷 94, 编号 9 (2022) |
Original articles |
Prevalence of combination of functional dyspepsia and irritable bowel syndrome: a meta-analysis of studies using the Rome III–IV Criteria |
 (Rus)
|
卷 94, 编号 10 (2022) |
Original articles |
Efficacy of Saccharomyces boulardii CNCM I-745 probiotic drug in the prevention and treatment of diarrhea in hospitalized patients with new coronavirus infection COVID-19 |
 (Rus)
|
卷 94, 编号 12 (2022) |
Original articles |
Efficacy of esophagus protection in complex treatment of erosive gastroesophageal reflux disease: a systematic review and meta-analysis of controlled trials |
 (Rus)
|
卷 95, 编号 1 (2023) |
Original articles |
Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study |
 (Rus)
|
卷 95, 编号 2 (2023) |
Original articles |
Effectiveness of empirical Helicobacter pylori eradication therapy with furazolidone in Russia: results from the European Registry on Helicobacter pylori Management (Hp-EuReg) |
 (Rus)
|
卷 95, 编号 2 (2023) |
Original articles |
Comparative analysis of the intestinal microbiota in patients with exocrine pancreatic insufficiency of various severity |
 (Rus)
|
卷 95, 编号 8 (2023) |
Reviews |
Current status and prospects of using the prokinetic acotiamide in gastroenterology: A review |
 (Rus)
|
卷 95, 编号 12 (2023) |
Original articles |
Study of the resistome of human microbial communities using a targeted panel of antibiotic resistance genes in COVID-19 patients |
 (Rus)
|
卷 96, 编号 8 (2024): Treatment issues |
Original articles |
Prevalence of gastroesophageal reflux disease in Russia: a meta-analysis of population-based studies |
 (Rus)
|
卷 96, 编号 8 (2024): Treatment issues |
Original articles |
Personalized diagnosis of patients with gastroesophageal reflux disease using 24-hour pH-impedance testing and high-resolution esophageal manometry |
 (Rus)
|
卷 97, 编号 2 (2025): Вопросы гастроэнтерологии |
Original articles |
Trends of antibiotic resistance of Helicobacter pylori in Moscow |
 (Rus)
|
卷 97, 编号 2 (2025): Вопросы гастроэнтерологии |
Reviews |
Prevalence and risk of malnutrition in patients with chronic pancreatitis: A systematic review and meta-analysis |
 (Rus)
|
卷 97, 编号 5 (2025): Issues of rheumatology |
Reviews |
Trends in the prevalence of Helicobacter pylori infection among adults in Moscow: a systematic review and meta-analysis |
 (Rus)
|